AMP Events Calendar

09/30: From variants to value

1 p.m. Eastern on Sept. 30

From variants to value: The expanding role of clinical bioinformatics

Speaker: Srika Chamala, Ph.D., Children's Hospital of Los Angeles & University of Southern California

Moderator: Rebecca Yee, Ph.D., George Washington University

10/07: Advancing hematologic cancer research through multi-omics analysis

12 p.m. Eastern on Oct. 7

Advancing hematologic cancer research through multi-omics analysis, including sensitive Archer™ AMP chemistry: Insights from Children's Hospital of Philadelphia

Speaker: Marilyn M. Li, M.D., Children's Hospital of Philadelphia

Moderator: Emily Davis, M.B.A., Integrated DNA Technologies

10/09: Cell-free DNA from CSF

Oct. 9 at 1 p.m. Eastern

Cell-free DNA from cerebrospinal fluid for diagnosis and molecular testing of brain tumors

Speaker: Tejus A. Bale, M.D., Ph.D., Memorial Sloan Kettering Cancer Center

Moderator: Pawel Mroz, M.D., Ph.D., University of Minnesota Medical School

10/16: NGS applications: Assessing clonality and diversity

1 p.m. Eastern on Oct. 16

NGS applications: Assessing clonality and diversity

Speakers:

Rebecca Ramesh, M.D., Hospital of the University of Pennsylvania

Jeremiah X. Karrs, D.O., Dartmouth Hitchcock/Geisel School of Medicine

10/16: Provider-friendly NGS molecular biomarker report

3 p.m. on Oct. 16, 2025

Developing Consensus for a More Provider-Friendly Next-Generation Sequencing Molecular Biomarker Report

Speaker: Jane Gibson, Ph.D., University of Central Florida College of Medicine

Moderator: Anthony Snow, M.D., University of Iowa Hospitals and Clinics

10/21: Introduction to molecular biomarkers: Evidence and guidelines

4 p.m. Eastern on Oct. 21, 2025

Introduction to molecular biomarkers: Evidence and guidelines

Speakers:

Eric Vail, M.D., Cedars–Sinai Medical Center

Paul M. Waring, Ph.D., Translational Pathology Consulting Services

This webinar is part of the Current Concepts in Molecular Testing for HR+/HER2- Metastatic Breast Cancer series.

10/27: Molecular testing strategies and evaluation of assay performance

4 p.m. Eastern on Oct. 27, 2025

Molecular testing strategies and evaluation of assay performance

Speakers:

Katherine B. Geiersbach, M.D., Mayo Clinic

Shuko Harada, M.D., University of Alabama at Birmingham

This webinar is part of the Current Concepts in Molecular Testing for HR+/HER2- Metastatic Breast Cancer series.

10/30: Applying molecular testing in practice

2 p.m. Eastern on Oct. 30, 2025

Applying molecular testing in practice with case discussions and expert panel

Speaker: Karthik Giridhar, M.D., Mayo Clinic

This webinar is part of the Current Concepts in Molecular Testing for HR+/HER2- Metastatic Breast Cancer series.